News

The study results also showed numerically lower rates of major and clinically relevant non-major bleeding in patients treated with apixaban compared with those treated with enoxaparin. The results

Hizentra, a once weekly immunoglobulin (Ig) replacement therapy, provides effective protection against infection by maintaining a steady and normal level of immunoglobulin in the body. CSL Behring claimed

LIMS-on-Demand can reduce the capital investment associated with traditional LIMS implementation and validation by eliminating the need for extensive software testing and installation. On-demand access provides a more

OmniComm claimed that TrialOne provides all necessary web-based tools used to recruit study volunteers, schedule screening appointments, collect screening data, directly capture real-time data, track sample transfers and

GOG is a multidisciplinary cooperative clinical trial research group focused on the study of gynecologic malignancies. GOG is conducting Phase III trials in ovarian cancer and other gynecologic

Health Sciences International, based in Connecticut, aims to conduct quality phase I-IV trial research with key therapeutic areas of focus including cardiology, vascular disorders, CNS, endocrinology and internal

In the Connection trial, Dimebon did not meet its co-primary or secondary efficacy endpoints compared to placebo. Co-primary endpoints were measures of cognition and global function. Dimebon was

CancerTYPE ID is a diagnostic test which predicts cancer origin in patients whose primary cancer was initially ‘unknown or uncertain’ using conventional diagnostics. Knowing the site where the

Aspen’s facility manufactures Penems and Penicillins and was originally divested to Aspen in 2007, at the time when company exited from Latam operations. The facility is forecasted to